Previously, McCoy et al. [20] found that by stably reintroducing either AQP1 or AQP4 into glioma cell lines, AQP4 could actually reduce the migratory ability of the cell, which is inconsistent with the results of the study performed by Ding et al. [17, 18]. This evidence concerns the gene AQP4 and central nervous system cancer.